Skip to main content

Table 1 Distribution of patients with and without inhibitor development, high and low responders, transient, slowly resolving and permanent, dependent on the severity of the disease

From: High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance

 

Severe

Moderate

Mild

Total

High responders

Low responders

OR

 

n = 434

n = 60

n = 30

n = 524

n = 79

n = 101

(*)

Without inhibitor

266

50

28

344

   

With inhibitor

168

10

2

180

   

Transient

64 (38%)

5 (50%)

1 (50%)

70 (39%)

8 (10%)

62 (61%)

-

Slowly resolving

44 (26%)

2 (20%)

1 (50%)

47 (26%)

15 (19%)

32 (32%)

3.6

Permanent

60 (36%)

3 (30%)

0

63 (35%)

56 (71%)

7 (7%)

62

  1. The condition of HR at the onset confers the highest risk of persistent inhibitor (56 out of 79, 71%) while only a minority of the patients become persistent when the onset is as LR (7 out of 101, 7%).
  2. (*)The OR represents the risk of having a permanent or slow resolving inhibitor for those being HR as compared to those being LR.